Traws Pharma, Inc.
General ticker "TRAW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.0M (TTM average)
Traws Pharma, Inc. follows the US Stock Market performance with the rate: 16.6%.
Estimated limits based on current volatility of 7.3%: low 1.39$, high 1.60$
Factors to consider:
- Total employees count: 64 as of 2013
Short-term TRAW quotes
Long-term TRAW plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.23MM | $0.23MM | $2.79MM |
| Operating Expenses | $20.52MM | $142.60MM | $20.66MM |
| Operating Income | $-20.30MM | $-142.37MM | $-17.88MM |
| Non-Operating Income | $1.35MM | $-24.15MM | $27.05MM |
| R&D Expense | $11.43MM | $12.85MM | $12.14MM |
| Income(Loss) | $-18.95MM | $-166.52MM | $9.17MM |
| Profit(Loss)* | $-18.95MM | $-54.67MM | $9.17MM |
| Stockholders Equity | $10.67MM | $-31.63MM | $-0.63MM |
| Assets | $22.68MM | $24.96MM | $10.62MM |
| Operating Cash Flow | $-17.93MM | $-29.79MM | $-18.18MM |
| Capital expenditure | $0.01MM | $0.00MM | $2.58MM |
| Investing Cash Flow | $-0.01MM | $-3.65MM | $-2.58MM |
| Financing Cash Flow | $0.00MM | $33.98MM | $3.20MM |
| Earnings Per Share** | $-22.57 | $-35.21 | $1.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.